HUP0102057A2 - Benzofuroxánszármazékok alkalmazása angina pectoris kezelésében - Google Patents

Benzofuroxánszármazékok alkalmazása angina pectoris kezelésében

Info

Publication number
HUP0102057A2
HUP0102057A2 HU0102057A HUP0102057A HUP0102057A2 HU P0102057 A2 HUP0102057 A2 HU P0102057A2 HU 0102057 A HU0102057 A HU 0102057A HU P0102057 A HUP0102057 A HU P0102057A HU P0102057 A2 HUP0102057 A2 HU P0102057A2
Authority
HU
Hungary
Prior art keywords
atom
alkyl group
angina pectoris
group
hydrogen atom
Prior art date
Application number
HU0102057A
Other languages
English (en)
Inventor
Alangudi Sankaranarayanan
Original Assignee
Torrent Pharmaceuticals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrent Pharmaceuticals Ltd. filed Critical Torrent Pharmaceuticals Ltd.
Publication of HUP0102057A2 publication Critical patent/HUP0102057A2/hu
Publication of HUP0102057A3 publication Critical patent/HUP0102057A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

A találmány (I) általános képletű benzofuroxánvegyületek ésgyógyászatilag elfogadható sóik kardiovaszkuláris rendellenességek,például szívkoszorúér-betegségek kezelésére való alkalmazásáravonatkozik, a képletben R jelentése halogénatom, acetoxi-, -X-R' vagy-C(O)NR< R<' általános képletű vagy -C(O)-C1 csoport, ahol X jelentéseoxigén- vagy kénatom, -C(O)- vagy -C(O)O- csoport, R' jelentésehidrogénatom vagy egyenes vagy elágazó láncú 1-8 szénatomosalkilcsoport, R< és R<' jelentése egymástól függetlenül hidrogénatom,egyenes vagy elágazó láncú 1-8 szénatomos alkilcsoport vagy R< és R<'heteroatom nélkül vagy heteroatommal, így oxigén- vagynitrogénatommal, ahol a nitrogénatom helyettesítője hidrogénatom vagykevés szénatomos alkilcsoport, összekapcsolódik. Ó
HU0102057A 1998-05-22 1999-05-17 Use of benzofuroxan derivatives in treating angina pectoris HUP0102057A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN935CA1998 IN188837B (hu) 1998-05-22 1998-05-22
PCT/IB1999/000893 WO1999061018A1 (en) 1998-05-22 1999-05-17 Use of benzofuroxan derivatives in treating angina pectoris

Publications (2)

Publication Number Publication Date
HUP0102057A2 true HUP0102057A2 (hu) 2001-11-28
HUP0102057A3 HUP0102057A3 (en) 2002-12-28

Family

ID=11085434

Family Applications (2)

Application Number Title Priority Date Filing Date
HU0102057A HUP0102057A3 (en) 1998-05-22 1999-05-17 Use of benzofuroxan derivatives in treating angina pectoris
HU0101584A HUP0101584A3 (en) 1998-05-22 1999-05-17 Benzofuroxan derivatives and their use in treating angina pectoris

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU0101584A HUP0101584A3 (en) 1998-05-22 1999-05-17 Benzofuroxan derivatives and their use in treating angina pectoris

Country Status (16)

Country Link
US (2) US6248895B1 (hu)
EP (2) EP1079829B1 (hu)
JP (2) JP2002516275A (hu)
CN (2) CN1301258A (hu)
AT (2) ATE245419T1 (hu)
AU (2) AU3623299A (hu)
BR (2) BR9910628A (hu)
CA (2) CA2333001A1 (hu)
CZ (1) CZ20004072A3 (hu)
DE (2) DE69909782D1 (hu)
ES (1) ES2222029T3 (hu)
HU (2) HUP0102057A3 (hu)
IN (1) IN188837B (hu)
PT (1) PT1080081E (hu)
RU (2) RU2209065C2 (hu)
WO (2) WO1999061430A1 (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
AU2002366756A1 (en) * 2001-12-20 2003-07-09 Alangudi Sankaranarayanan Use of benzofuroxan derivatives as antiplatelet agents
AU2003226603A1 (en) 2002-04-19 2003-11-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
AU2003278565A1 (en) * 2002-10-25 2004-05-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
US20060166894A1 (en) * 2002-11-29 2006-07-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ace-inhibitors having antioxidant and no-donor activity
US7093310B2 (en) * 2005-01-03 2006-08-22 Miranda Industries, Inc. Beddress
US8822509B2 (en) 2006-12-29 2014-09-02 The University Of Queensland Pain-relieving compositions and uses therefor
CN101270068B (zh) * 2008-04-23 2011-05-18 常州亚邦齐晖医药化工有限公司 一种2-硝基-4-丙硫基苯胺的制备方法
AU2009266408C1 (en) * 2008-07-02 2015-12-10 The University Of Queensland Pain-relieving compositions of furoxan NO donors and uses thereof
RU2515413C2 (ru) * 2012-07-05 2014-05-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Производные 1,2,5-оксадиазолов, обладающие анти-вич активностью, фармацевтическая композиция, способ ингибирования интегразы вич-1
US8945338B2 (en) 2013-03-15 2015-02-03 Henkel US IP LLC Anaerobic curable compositions
CN104592145B (zh) * 2015-01-15 2017-05-17 山东大学 一种苯并氧化呋咱组蛋白去乙酰化酶抑制剂及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567728A (en) * 1968-07-05 1971-03-02 Pfizer Process for the preparation of phenazine di-n-oxides and related compounds
US4014893A (en) * 1973-05-11 1977-03-29 Imperial Chemical Industries Limited 3,4-Cycloalkano furoxans
US4185018A (en) * 1978-08-21 1980-01-22 Ciba-Geigy Corporation Process for producing benzofurazan-1-oxides
US4544400A (en) * 1982-02-22 1985-10-01 Zoecon Corporation Compositions
JPS6072874A (ja) * 1983-09-28 1985-04-24 Kazuhiro Imai ２，１，３−ベンゾオキサジアゾ−ルの新規誘導体
JPS6383078A (ja) * 1986-09-25 1988-04-13 Honsyu Kagaku Kogyo Kk ベンゾフラザン−１−オキシドの製造方法
US5272164A (en) 1988-12-27 1993-12-21 Kirin Beer Kabushiki Kaisha Carboximidamide derivatives
US5032604A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Class III antiarrhythmic agents
DE4218977A1 (de) * 1992-06-10 1993-12-16 Cassella Ag Annellierte 1,2,5-Oxadiazol-2-oxide
DE4220264A1 (de) 1992-06-20 1993-12-23 Cassella Ag Phenyl-1,2,5-oxadiazol-carbonamid-2-oxide
US6110935A (en) * 1997-02-13 2000-08-29 The Regents Of The University Of California Benzofurazan compounds for enhancing glutamatergic synaptic responses

Also Published As

Publication number Publication date
DE69909782D1 (de) 2003-08-28
DE69918431T2 (de) 2005-07-14
RU2209065C2 (ru) 2003-07-27
IN188837B (hu) 2002-11-09
CA2333001A1 (en) 1999-12-02
HUP0102057A3 (en) 2002-12-28
EP1079829B1 (en) 2003-07-23
JP3378239B2 (ja) 2003-02-17
CN1301258A (zh) 2001-06-27
EP1080081A1 (en) 2001-03-07
JP2002516275A (ja) 2002-06-04
ES2222029T3 (es) 2005-01-16
US6232331B1 (en) 2001-05-15
JP2002516317A (ja) 2002-06-04
DE69918431D1 (de) 2004-08-05
ATE245419T1 (de) 2003-08-15
EP1079829A1 (en) 2001-03-07
AU3623299A (en) 1999-12-13
CN1302205A (zh) 2001-07-04
BR9910628A (pt) 2001-01-30
WO1999061430A1 (en) 1999-12-02
HUP0101584A2 (hu) 2001-11-28
CZ20004072A3 (cs) 2001-08-15
ATE270279T1 (de) 2004-07-15
CA2332950A1 (en) 1999-12-02
PT1080081E (pt) 2004-10-29
EP1080081B1 (en) 2004-06-30
US6248895B1 (en) 2001-06-19
RU2222532C2 (ru) 2004-01-27
BR9910637A (pt) 2001-02-06
WO1999061018A1 (en) 1999-12-02
HUP0101584A3 (en) 2002-12-28
AU3623399A (en) 1999-12-13

Similar Documents

Publication Publication Date Title
HUP0102057A2 (hu) Benzofuroxánszármazékok alkalmazása angina pectoris kezelésében
NO20044501L (no) [1,4] diazenino [6,7,1-IJ] kinolin-derivater som antipsykotis og antifedme-midler
PT1178045E (pt) Derivados de azaindole-etilamina como agentes de ligacao de receptores de acetilcolina nicotinicos
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
BR0014178A (pt) Derivados de ácido dicarboxìlico com propriedades farmacêuticas
PT1147110E (pt) Derivados de pirazino (aza)-indol
BR9912621A (pt) Derivado de ácido aminometilcarboxìlico, composição farmacêutica, e, uso de um derivado de ácido aminometilcarboxìlico
PT896533E (pt) Pentafluorobenzenosulfonamidas e analogos
BR0311541A (pt) indol, azaindol e 4-aquenil piperidina amidas heterocìclicas relacionadas
DE69724811D1 (de) Pentafluorobenzensulfonamide und analoge
NO174549C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, asymmetrisk substituerte, heterocykliske forbindelser
EA200400223A1 (ru) Новые производные 2h-пиридазин-3-она, фармацевтические композиции, содержащие эти производные, и способ получения активного ингредиента
ATE383858T1 (de) Substituierte tetrhydroisochinolin-derivate zur behandlung von entzündlichen erkrankungen
DK0765320T3 (da) Benzimidazolonderivater med central dopaminerg aktivitet
FI970469A0 (fi) Bentsimidatsolijohdannaisia, joilla on dopaminerginen aktiivisuus
HUP0102025A2 (hu) Diaril-1,3,4-oxadiazolon-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
MX9307079A (es) Mejoras en composiciones farmaceuticas para el tratamiento de trastornos funcionales de las vias intestinales y mejoras en un procedimiento para la preparacion de dichas composiciones.
DE69600329D1 (de) Benzothiazol-Derivate
DK0570850T3 (da) Benzo(b)thiophen-3-yl-piperaziner, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
ATE184282T1 (de) Cyclopropan-derivate und diese enthaltende antivirale mittel
EA200001157A2 (ru) Новые замещенные производные (дигидро)бензоксазина и (дигидро)бензотиазина, способ их получения и содержащие их фармацевтические композиции
MY104630A (en) 4(1h) ouinoline derivatives
EA200501053A1 (ru) Производные 1,2,4-триаминобензола, пригодные для лечения расстройств центральной нервной системы
MX9709980A (es) Ciertos derivados de bencilamina sustituidos: una nueva clase de ligandos especificos del neuropeptido y1.
MX9703349A (es) Ligandos especificos del neuropeptido y1.